Navidea Biopharma (NAVB) Posts Narrower than Expected Q1 Loss
Tweet Send to a Friend
Navidea Biopharmaceuticals (AMEX: NAVB) reported Q1 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
